Details of issuance or disposal
Exercise status report for stock acquisition rights with an exercise price adjustment clause
New shares: 210,000; treasury shares transferred: 0
0.29% (exercise ratio related to exercise restrictions; 210,000 shares delivered across all series combined / 71,981,758 listed shares as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status report for stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | New shares: 210,000; treasury shares transferred: 0 |
| Dilution Rate | 0.29% (exercise ratio related to exercise restrictions; 210,000 shares delivered across all series combined / 71,981,758 listed shares as of the payment date for the issuance) |
| Total number of issued shares | 90,735,458 shares (as of the end of the month preceding the reporting month) → Not disclosed |
| Exercise price | ¥94 during the reporting month (¥96 from 1 to 14 September). The detailed lower limit under the adjustment clause is Not disclosed |
| Number of Stock Acquisition Rights | Total number issued: Not disclosed. Unexercised balance of 252,470 units as of the end of the month preceding the reporting month, and 250,370 units as of the end of the reporting month |
| Procedures under the Corporate Code of Conduct | Report on compliance with the exercise restrictions under Article 434 of the Tokyo Stock Exchange's Regulations on Listing of Securities and the Japan Securities Dealers Association's Rules Concerning the Handling of Third-Party Allotments and Other Matters |
| Most recent equity financing | The 22nd Series of Stock Acquisition Rights (with Exercise Price Adjustment Clause) issued on 30 October 2025 |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the 22nd series of stock acquisition rights for September 2026.